Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Douglas S. Krakower, M.D.

Co-Author

This page shows the publications co-authored by Douglas Krakower and Kenneth Mayer.
Connection Strength

21.795
  1. Krakower DS, Mayer KH. Routine screening for hepatitis C in MSM on HIV PrEP. Nat Rev Urol. 2019 May; 16(5):272-274.
    View in: PubMed
    Score: 0.917
  2. Krakower D, Maloney KM, Powell VE, Levine K, Grasso C, Melbourne K, Marcus JL, Mayer KH. Patterns and clinical consequences of discontinuing HIV preexposure prophylaxis during primary care. J Int AIDS Soc. 2019 02; 22(2):e25250.
    View in: PubMed
    Score: 0.901
  3. Mayer KH, Chan PA, R Patel R, Flash CA, Krakower DS. Evolving Models and Ongoing Challenges for HIV Preexposure Prophylaxis Implementation in the United States. J Acquir Immune Defic Syndr. 2018 02 01; 77(2):119-127.
    View in: PubMed
    Score: 0.841
  4. Krakower DS, Cohen SE, Mayer KH. Top Questions in ID: Pre-exposure Prophylaxis for HIV. Open Forum Infect Dis. 2017; 4(4):ofx185.
    View in: PubMed
    Score: 0.816
  5. Krakower DS, Ware NC, Maloney KM, Wilson IB, Wong JB, Mayer KH. Differing Experiences with Pre-Exposure Prophylaxis in Boston Among Lesbian, Gay, Bisexual, and Transgender Specialists and Generalists in Primary Care: Implications for Scale-Up. AIDS Patient Care STDS. 2017 07; 31(7):297-304.
    View in: PubMed
    Score: 0.803
  6. Krakower DS, Maloney KM, Grasso C, Melbourne K, Mayer KH. Primary care clinicians' experiences prescribing HIV pre-exposure prophylaxis at a specialized community health centre in Boston: lessons from early adopters. J Int AIDS Soc. 2016; 19(1):21165.
    View in: PubMed
    Score: 0.768
  7. Mayer KH, Krakower DS. Editorial Commentary: Can We Afford to Control the HIV Epidemic With Antiretrovirals? Can We Afford Not to Do So? Clin Infect Dis. 2016 12 01; 63(11):1505-1507.
    View in: PubMed
    Score: 0.761
  8. Mayer KH, Krakower DS. Antiretrovirals for HIV Treatment and Prevention: The Challenges of Success. JAMA. 2016 Jul 12; 316(2):151-3.
    View in: PubMed
    Score: 0.755
  9. Krakower DS, Mayer KH. Renal Function and Tenofovir Disoproxil Fumarate for Preexposure Prophylaxis: How Safe Is Safe Enough? J Infect Dis. 2016 10 01; 214(7):983-5.
    View in: PubMed
    Score: 0.744
  10. Krakower DS, Mayer KH. The role of healthcare providers in the roll out of preexposure prophylaxis. Curr Opin HIV AIDS. 2016 Jan; 11(1):41-8.
    View in: PubMed
    Score: 0.728
  11. Krakower DS, Mayer KH. Infection in 2015: HIV protection with PrEP - implications for controlling other STIs. Nat Rev Urol. 2016 Feb; 13(2):72-4.
    View in: PubMed
    Score: 0.724
  12. Krakower DS, Beekmann SE, Polgreen PM, Mayer KH. Diffusion of Newer HIV Prevention Innovations: Variable Practices of Frontline Infectious Diseases Physicians. Clin Infect Dis. 2016 Jan 01; 62(1):99-105.
    View in: PubMed
    Score: 0.713
  13. Mayer KH, Krakower DS. Editorial Commentary: Scaling Up Antiretroviral Preexposure Prophylaxis: Moving From Trials to Implementation. Clin Infect Dis. 2015 Nov 15; 61(10):1598-600.
    View in: PubMed
    Score: 0.709
  14. Krakower DS, Oldenburg CE, Mitty JA, Wilson IB, Kurth AE, Maloney KM, Gallagher D, Mayer KH. Knowledge, Beliefs and Practices Regarding Antiretroviral Medications for HIV Prevention: Results from a Survey of Healthcare Providers in New England. PLoS One. 2015; 10(7):e0132398.
    View in: PubMed
    Score: 0.704
  15. Mayer KH, Krakower DS. Editorial commentary: uncoupling epidemiological synergy: new opportunities for HIV prevention for men who have sex with men. Clin Infect Dis. 2015 Jul 15; 61(2):288-90.
    View in: PubMed
    Score: 0.692
  16. Krakower DS, Jain S, Mayer KH. Antiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxis. Curr HIV/AIDS Rep. 2015 Mar; 12(1):127-38.
    View in: PubMed
    Score: 0.687
  17. Krakower DS, Mayer KH. Pre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challenges. Drugs. 2015 Feb; 75(3):243-51.
    View in: PubMed
    Score: 0.683
  18. Krakower D, Ware N, Mitty JA, Maloney K, Mayer KH. HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study. AIDS Behav. 2014 Sep; 18(9):1712-21.
    View in: PubMed
    Score: 0.664
  19. Krakower D, Mayer KH. Engaging healthcare providers to implement HIV pre-exposure prophylaxis. Curr Opin HIV AIDS. 2012 Nov; 7(6):593-9.
    View in: PubMed
    Score: 0.584
  20. Krakower D, Mayer KH. What primary care providers need to know about preexposure prophylaxis for HIV prevention: a narrative review. Ann Intern Med. 2012 Oct 02; 157(7):490-7.
    View in: PubMed
    Score: 0.581
  21. Krakower DS, Mimiaga MJ, Rosenberger JG, Novak DS, Mitty JA, White JM, Mayer KH. Limited Awareness and Low Immediate Uptake of Pre-Exposure Prophylaxis among Men Who Have Sex with Men Using an Internet Social Networking Site. PLoS One. 2012; 7(3):e33119.
    View in: PubMed
    Score: 0.561
  22. Mayer KH, Krakower D. Antiretroviral medication and HIV prevention: new steps forward and new questions. Ann Intern Med. 2012 Feb 21; 156(4):312-4.
    View in: PubMed
    Score: 0.553
  23. Krakower D, Mayer KH. Promising prevention approaches: tenofovir gel and prophylactic use of antiretroviral medications. Curr HIV/AIDS Rep. 2011 Dec; 8(4):241-8.
    View in: PubMed
    Score: 0.548
  24. Fontenot HB, Krakower D, White BP, Marquez SM, Dormitzer J, Psaros C, O'Cleirigh C, Mayer KH. Condom use philosophy and behaviors among young men who have sex with men: Variations among HIV pre-exposure prophylaxis users and nonusers. J Am Assoc Nurse Pract. 2020 Apr 08.
    View in: PubMed
    Score: 0.245
  25. Calabrese SK, Krakower DS, Willie TC, Kershaw TS, Mayer KH. US Guideline Criteria for Human Immunodeficiency Virus Preexposure Prophylaxis: Clinical Considerations and Caveats. Clin Infect Dis. 2019 08 16; 69(5):884-889.
    View in: PubMed
    Score: 0.234
  26. Krakower DS, Gruber S, Hsu K, Menchaca JT, Maro JC, Kruskal BA, Wilson IB, Mayer KH, Klompas M. Development and validation of an automated HIV prediction algorithm to identify candidates for pre-exposure prophylaxis: a modelling study. Lancet HIV. 2019 10; 6(10):e696-e704.
    View in: PubMed
    Score: 0.232
  27. Biello KB, Psaros C, Krakower DS, Marrow E, Safren SA, Mimiaga MJ, Hightow-Weidman L, Sullivan P, Mayer KH. A Pre-Exposure Prophylaxis Adherence Intervention (LifeSteps) for Young Men Who Have Sex With Men: Protocol for a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2019 Jan 29; 8(1):e10661.
    View in: PubMed
    Score: 0.225
  28. Marcus JL, Levine K, Grasso C, Krakower DS, Powell V, Mayer KH. Marcus et al. Respond. Am J Public Health. 2018 12; 108(12):e27-e28.
    View in: PubMed
    Score: 0.223
  29. Marcus JL, Levine K, Grasso C, Krakower DS, Powell V, Bernstein KT, Boswell S, Mayer KH. HIV Preexposure Prophylaxis as a Gateway to Primary Care. Am J Public Health. 2018 10; 108(10):1418-1420.
    View in: PubMed
    Score: 0.217
  30. Hoornenborg E, Krakower DS, Prins M, Mayer KH. Pre-exposure prophylaxis for MSM and transgender persons in early adopting countries. AIDS. 2017 10 23; 31(16):2179-2191.
    View in: PubMed
    Score: 0.206
  31. Calabrese SK, Krakower DS, Mayer KH. Integrating HIV Preexposure Prophylaxis (PrEP) Into Routine Preventive Health Care to Avoid Exacerbating Disparities. Am J Public Health. 2017 12; 107(12):1883-1889.
    View in: PubMed
    Score: 0.206
  32. Mayer KH, Maloney KM, Levine K, King D, Grasso C, Krakower DS, Rosenberg ES, Boswell SL. Sociodemographic and Clinical Factors Associated With Increasing Bacterial Sexually Transmitted Infection Diagnoses in Men Who Have Sex With Men Accessing Care at a Boston Community Health Center (2005-2015). Open Forum Infect Dis. 2017; 4(4):ofx214.
    View in: PubMed
    Score: 0.206
  33. Hoornenborg E, Krakower DS, Prins M, Mayer KH. Preexposure prophylaxis for men who have sex with men and transgender persons in early adopting countries: a narrative review. AIDS. 2017 Aug 28.
    View in: PubMed
    Score: 0.204
  34. Maloney KM, Krakower DS, Ziobro D, Rosenberger JG, Novak D, Mayer KH. Culturally Competent Sexual Healthcare as a Prerequisite for Obtaining Preexposure Prophylaxis: Findings from a Qualitative Study. LGBT Health. 2017 08; 4(4):310-314.
    View in: PubMed
    Score: 0.200
  35. Silapaswan A, Krakower D, Mayer KH. Pre-Exposure Prophylaxis: A Narrative Review of Provider Behavior and Interventions to Increase PrEP Implementation in Primary Care. J Gen Intern Med. 2017 Feb; 32(2):192-198.
    View in: PubMed
    Score: 0.192
  36. Mayer KH, Oldenburg CE, Novak DS, Elsesser SA, Krakower DS, Mimiaga MJ. Early Adopters: Correlates of HIV Chemoprophylaxis Use in Recent Online Samples of US Men Who Have Sex with Men. AIDS Behav. 2016 07; 20(7):1489-98.
    View in: PubMed
    Score: 0.188
  37. Elsesser SA, Oldenburg CE, Biello KB, Mimiaga MJ, Safren SA, Egan JE, Novak DS, Krakower DS, Stall R, Mayer KH. Seasons of Risk: Anticipated Behavior on Vacation and Interest in Episodic Antiretroviral Pre-exposure Prophylaxis (PrEP) Among a Large National Sample of U.S. Men Who have Sex with Men (MSM). AIDS Behav. 2016 07; 20(7):1400-7.
    View in: PubMed
    Score: 0.188
  38. Mayer KH, Krakower DS, Boswell SL. Antiretroviral Preexposure Prophylaxis: Opportunities and Challenges for Primary Care Physicians. JAMA. 2016 Mar 01; 315(9):867-8.
    View in: PubMed
    Score: 0.184
  39. Stack C, Oldenburg C, Mimiaga M, Elsesser SA, Krakower D, Novak DS, Egan JE, Stall R, Safren S, Mayer KH. Sexual Behavior Patterns and PrEP Dosing Preferences in a Large Sample of North American Men Who Have Sex With Men. J Acquir Immune Defic Syndr. 2016 Jan 01; 71(1):94-101.
    View in: PubMed
    Score: 0.182
  40. Mayer KH, Hosek S, Cohen S, Liu A, Pickett J, Warren M, Krakower D, Grant R. Antiretroviral pre-exposure prophylaxis implementation in the United States: a work in progress. J Int AIDS Soc. 2015; 18(4 Suppl 3):19980.
    View in: PubMed
    Score: 0.176
  41. Jain S, Krakower DS, Mayer KH. The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention. Clin Infect Dis. 2015 Jun 01; 60 Suppl 3:S200-4.
    View in: PubMed
    Score: 0.175
  42. Oldenburg CE, Perez-Brumer AG, Hatzenbuehler ML, Krakower D, Novak DS, Mimiaga MJ, Mayer KH. State-level structural sexual stigma and HIV prevention in a national online sample of HIV-uninfected MSM in the United States. AIDS. 2015 Apr 24; 29(7):837-45.
    View in: PubMed
    Score: 0.173
  43. Flash CA, Stone VE, Mitty JA, Mimiaga MJ, Hall KT, Krakower D, Mayer KH. Perspectives on HIV prevention among urban black women: a potential role for HIV pre-exposure prophylaxis. AIDS Patient Care STDS. 2014 Dec; 28(12):635-42.
    View in: PubMed
    Score: 0.169
  44. Oldenburg C, Perez-Brumer A, Hatzenbuehler M, Krakower D, Novak D, Mimiaga M, Mayer K. Structural Stigma Affects Access to Pre- and Post-exposure Prophylaxis and HIV Risk among Men Who Have Sex with Men (MSM) in the United States. AIDS Res Hum Retroviruses. 2014 Oct; 30 Suppl 1:A22-3.
    View in: PubMed
    Score: 0.167
  45. Mayer KH, Oldenburg C, Novak DS, Krakower D, Mimiaga MJ. Differences in PrEP Knowledge and Use in U.S. MSM Users of a Popular Sexual Networking Site Surveyed in August 2013 and January 2014. AIDS Res Hum Retroviruses. 2014 Oct; 30 Suppl 1:A91-2.
    View in: PubMed
    Score: 0.167
  46. Mimiaga MJ, White JM, Krakower DS, Biello KB, Mayer KH. Suboptimal awareness and comprehension of published preexposure prophylaxis efficacy results among physicians in Massachusetts. AIDS Care. 2014; 26(6):684-93.
    View in: PubMed
    Score: 0.156
  47. White JM, Mimiaga MJ, Krakower DS, Mayer KH. Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention. AIDS Patient Care STDS. 2012 Jul; 26(7):395-405.
    View in: PubMed
    Score: 0.142
  48. Flash C, Krakower D, Mayer KH. The Promise of Antiretrovirals for HIV Prevention. Curr Infect Dis Rep. 2012 Apr; 14(2):185-93.
    View in: PubMed
    Score: 0.140
  49. Gruber S, Krakower D, Menchaca JT, Hsu K, Hawrusik R, Maro JC, Cocoros NM, Kruskal BA, Wilson IB, Mayer KH, Klompas M. Using electronic health records to identify candidates for human immunodeficiency virus pre-exposure prophylaxis: An application of super learning to risk prediction when the outcome is rare. Stat Med. 2020 Jun 24.
    View in: PubMed
    Score: 0.062
  50. Sewell WC, Powell VE, Mayer KH, Ochoa A, Krakower DS, Marcus JL. Nondaily Use of HIV Preexposure Prophylaxis in a Large Online Survey of Primarily Men Who Have Sex With Men in the United States. J Acquir Immune Defic Syndr. 2020 Jun 01; 84(2):182-188.
    View in: PubMed
    Score: 0.062
  51. Calabrese SK, Tekeste M, Mayer KH, Magnus M, Krakower DS, Kershaw TS, Eldahan AI, Gaston Hawkins LA, Underhill K, Hansen NB, Betancourt JR, Dovidio JF. Considering Stigma in the Provision of HIV Pre-Exposure Prophylaxis: Reflections from Current Prescribers. AIDS Patient Care STDS. 2019 02; 33(2):79-88.
    View in: PubMed
    Score: 0.056
  52. Calabrese SK, Earnshaw VA, Underhill K, Krakower DS, Magnus M, Hansen NB, Mayer KH, Betancourt JR, Kershaw TS, Dovidio JF. Prevention paradox: Medical students are less inclined to prescribe HIV pre-exposure prophylaxis for patients in highest need. J Int AIDS Soc. 2018 06; 21(6):e25147.
    View in: PubMed
    Score: 0.054
  53. Calabrese SK, Earnshaw VA, Krakower DS, Underhill K, Vincent W, Magnus M, Hansen NB, Kershaw TS, Mayer KH, Betancourt JR, Dovidio JF. A Closer Look at Racism and Heterosexism in Medical Students' Clinical Decision-Making Related to HIV Pre-Exposure Prophylaxis (PrEP): Implications for PrEP Education. AIDS Behav. 2018 04; 22(4):1122-1138.
    View in: PubMed
    Score: 0.053
  54. Calabrese SK, Magnus M, Mayer KH, Krakower DS, Eldahan AI, Hawkins LAG, Underhill K, Hansen NB, Kershaw TS, Betancourt JR, Dovidio JF. "Support Your Client at the Space That They're in": HIV Pre-Exposure Prophylaxis (PrEP) Prescribers' Perspectives on PrEP-Related Risk Compensation. AIDS Patient Care STDS. 2017 Apr; 31(4):196-204.
    View in: PubMed
    Score: 0.050
  55. Calabrese SK, Earnshaw VA, Magnus M, Hansen NB, Krakower DS, Underhill K, Mayer KH, Kershaw TS, Betancourt JR, Dovidio JF. Sexual Stereotypes Ascribed to Black Men Who Have Sex with Men: An Intersectional Analysis. Arch Sex Behav. 2018 01; 47(1):143-156.
    View in: PubMed
    Score: 0.049
  56. Calabrese SK, Underhill K, Earnshaw VA, Hansen NB, Kershaw TS, Magnus M, Krakower DS, Mayer KH, Betancourt JR, Dovidio JF. Framing HIV Pre-Exposure Prophylaxis (PrEP) for the General Public: How Inclusive Messaging May Prevent Prejudice from Diminishing Public Support. AIDS Behav. 2016 07; 20(7):1499-513.
    View in: PubMed
    Score: 0.047
  57. Calabrese SK, Magnus M, Mayer KH, Krakower DS, Eldahan AI, Gaston Hawkins LA, Hansen NB, Kershaw TS, Underhill K, Betancourt JR, Dovidio JF. Putting PrEP into Practice: Lessons Learned from Early-Adopting U.S. Providers' Firsthand Experiences Providing HIV Pre-Exposure Prophylaxis and Associated Care. PLoS One. 2016; 11(6):e0157324.
    View in: PubMed
    Score: 0.047
  58. Blumenthal J, Jain S, Krakower D, Sun X, Young J, Mayer K, Haubrich R. Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEP. AIDS Behav. 2015 May; 19(5):802-10.
    View in: PubMed
    Score: 0.043
  59. Volk JE, Liu A, Vittinghoff E, Irvin R, Kroboth E, Krakower D, Mimiaga MJ, Mayer KH, Sullivan PS, Buchbinder SP. Sexual frequency and planning among at-risk men who have sex with men in the United States: implications for event-based intermittent pre-exposure prophylaxis. J Acquir Immune Defic Syndr. 2012 Sep 01; 61(1):112-5.
    View in: PubMed
    Score: 0.036
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.